News form our full member Wilmer Eye Institute at Johns Hopkins
While artificial intelligence suddenly seems to be everywhere, physician-scientists at Wilmer have been developing and evaluating AI tools for years. What started with one project by Neil Bressler, M.D., in partnership with the Johns Hopkins Applied Physics Lab (APL), has multiplied in number and complexity. Today, AI-related projects at Wilmer encompass everything from precision medicine to surgical training to drug discovery, with many patients and faculty members benefiting from the unique, collaborative environment at Johns Hopkins.
“What sets Wilmer apart from other academic eye centers is the breadth of projects using artificial intelligence,” says T.Y. Alvin Liu, M.D., director of Wilmer’s Precision Ophthalmology Center of Excellence. “We also have a deep bench of investigators involved in the entire life cycle of AI projects, from fundamental model design to translating data into useful AI clinical decision tools, and from implementation of FDA-approved AI tools on a health system level to the ethical and societal considerations of AI technology.”
Want to know more about education for nurses and allied health personnel?
Please join the WAEH Community of Practice: Research impact on clinical practice on 27 February 2024. With presenter Tendai Gwenhure, Clinical Educator (Lead for Student Nurse’s/ RTP Nurses), and Roxanne […]
New ISBCS Implementation Manual Released, Accompanied by BICAT-NL Implementation Project Website Launch
The Netherlands is a leading country in providing same-day bilateral cataract surgery as a treatment for cataracts. In a large study (coordinated by the University Eye Clinic Maastricht) involving 865 […]
Same-day bilateral cataract surgery – breaking down the barriers
WAEH Webinar The Netherlands is a leading country in providing same-day bilateral cataract surgery as a treatment for cataracts. In a large study (coordinated by the University Eye Clinic Maastricht) […]
Study calls for thorough investigation of patients with early signs of retinal vascular disease
News from our member Moorfields Eye Hospital NHS Foundation Trust, United Kingdom Patients with the eye condition Paracentral Acute Middle Maculopathy (PAMM) would benefit from further investigation, as their risk […]